Compound ID | 265
Class: Natural product antibiotic
| Agent Type: | Natural product; Small molecule; Indirect acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Cytostatic antibiotic which acts by inhibiting signal transduction pathways involving Rasp21 |
| Target Pathogen: | Active against Gram positives but not Gram-negatives except for Escherichia coli |
| Description: | Natural product from Streptomyces sp. soil isolate; also shows anti-tumour activity |
| Institute where first reported: | Taisho Pharmaceuticals, Japan |
| Year first mentioned: | 1995 |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/139584829 |
| Guide to Pharmacology: | IT-62-B |
| Citations: |
|